摘要
【目的】研究在卒中易感型自发性高血压大鼠(stroke-prone spontaneously hypertensiverat,SHR-SP)肾脏中,基质金属蛋白酶(Matrixmetalloproteinases,MMPs)-2,-9以及组织型基质金属蛋白酶抑制剂(tissue inhibitors of matrix metalloproteinases,TIMPs)-1,-2的表达与活性的变化。【方法】分别采用40只7周龄雄性SHR-SP大鼠及10只同周龄雄性Wistar-Kyoto大鼠作为高血压组与阴性对照组。观察期间定期测量各组大鼠无创鼠尾压。6个月后,处死存活大鼠留取血液及肾脏标本,测定血清肌酐及尿素氮浓度,采用组织病理染色观察两组大鼠肾脏组织学改变,采用明胶酶谱法分析存活大鼠肾脏MMP-2和MMP-9蛋白活性,并采用逆明胶酶谱法及蛋白质印迹分析TIMP-1和TIMP-2蛋白表达和活性。【结果】(1)明胶酶谱分析显示:SHR-SP肾脏中MMP-2活性较WKY组明显增高([3.28±1.17)vs.(1.26±0.62);P<0.01]。(2)逆明胶酶谱分析显示:高血压大鼠肾脏TIMP-2的活性明显高于WKY组([1.12±0.43)vs.(0.78±0.34),P<0.05]。(3)蛋白质印迹结果显示:高血压组大鼠肾脏TIMP-1、TIMP-2表达较对照组高([TIMP-1:(3.44±0.13)vs.(2.31±0.15),TIMP-2:(6.44±0.49)vs(.4.94±0.68),P<0.01]。【结论】SHR-SP肾脏组织中MMP-2及TIMP-2的活性增高,TIMP-1及TIMP-2的表达均明显升高。
[Objective] To investigate the expression and the activity of renal matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases in stroke-prone spontaneously hypertensive rats (SHR-SPs). [Methods] 40 male SHR-SPs of 7 weeks old were used as vehicle group and 10 male Wistar-Kyoto rats (WKY) at the same age were used as controls. Throughout the intervention, indirect tail-cuff systolic blood pressure was continuously measured. The survival rats were executed 6 months later. After the blood was collected to measure the plasma creatinine and urea nitrogen, some kidneytissues were embedded for pathological analysis. The activity of MMP-2 and MMP-9 were detected by gelatin zymography, The expression and the activity of tissue inhibitors of matrix metalloproteinase were detected by western blot and reverse zymography. [ Results] (1) Analysis of the activity of MMPs in kidney by zymography demonstrated that the activity of MMP-2 was markedly increased as compared with control group[(3.28 ± 1.17) vs. ( 1.26 ± 0.62); P 〈 0.01]. (2) The result of reverse zymography demonstrated that the activity of TIMP-2 was also increased in SHR-SPs[( 1.12 ± 0.43 ) vs. (0.78 ± 0.34), P 〈 0.05]. (3) Analysis of the expression of TIMPs in kidney by western blot demonstrated that the expression of TIMP-1 and TIMP-2 in SHR-SPs group was markedly increased as compared with controls [(TIMP-I: (3.44 ± 0.13) vs. (2.31 ± 0.15), TIMP-2:(6.44 ± 0.49) vs. (4.94 ± 0.68), P 〈 0.01]. [Conclusion]The results of present study showed that the activity of MMP-2, TIMP-2 and the expression of TIMP-1,-2 in the kidney of SHR-SPs were markedly increased.
出处
《武警后勤学院学报(医学版)》
CAS
2013年第3期161-165,F0004,共6页
Journal of Logistics University of PAP(Medical Sciences)
关键词
高血压
基质金属蛋白酶
组织型基质金属蛋白酶抑制剂
肾纤维化
Hypertension
Matrix metalloproteinases
Tissue Inhibitors of matrix metalloproteinases
Renal fibrosis